Glaxosmithkline | GSK - Action





Action Changement Date
AbbVie USD 5.05B 98M 2026-03
Amgen USD 6.19B 39M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
Aurora Cannabis CAD 230.56M 8.6M 2025-12
Bausch Health Companies USD 1.63B 31M 2025-12
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Canopy Growth CAD 105.56M 3.18M 2025-12
Corcept Therapeutics USD 12.89M 22K 2026-03
Drreddys Laboratories INR 79.01B 3.41B 2025-12
Eli Lilly USD 14.53B 785M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.12B 46M 2025-09
J&J USD 14.58B 392M 2026-03
Merck USD 6.48B 179M 2026-03
Novartis USD 6.29B 17M 2026-03
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Pfizer USD 10.67B 13M 2026-03
Phibro Animal Health USD 539.7M 22.35M 2026-03
Prestige Brands USD 159.13M 4.46M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Zoetis USD 2.55B 120M 2026-03